Cancer Research; Oncology; Lymphatic endothelial cells; Metastatic dissemination; In vitro models; Lymphangiogenesis; In vivo models; In silico methods; Computational models
Abstract :
[en] Lymphangiogenesis (LA) is the formation of new lymphatic vessels by lymphatic endothelial cells (LECs) sprouting from pre-existing lymphatic vessels. It is increasingly recognized as being involved in many diseases, such as in cancer and secondary lymphedema, which most often results from cancer treatments. For some cancers, excessive LA is associated with cancer progression and metastatic dissemination to the lymph nodes (LNs) through lymphatic vessels. The study of LA through in vitro, in vivo, and, more recently, in silico models is of paramount importance in providing novel insights and identifying the key molecular actors in the biological dysregulation of this process under pathological conditions. In this review, the different biological (in vitro and in vivo) models of LA, especially in a cancer context, are explained and discussed, highlighting their principal modeled features as well as their advantages and drawbacks. Imaging techniques of the lymphatics, complementary or even essential to in vivo models, are also clarified and allow the establishment of the link with computational approaches. In silico models are introduced, theoretically described, and illustrated with examples specific to the lymphatic system and the LA. Together, these models constitute a toolbox allowing the LA research to be brought to the next level.
Disciplines :
Engineering, computing & technology: Multidisciplinary, general & others Life sciences: Multidisciplinary, general & others
ULiège. ARC - Université de Liège. Actions de Recherche Concertées [BE] ERC - European Research Council [BE] F.R.S.-FNRS - Fund for Scientific Research [BE]
World Health Organization. Available online: Https://www.who.int/health-topics/cancer#tab=overview (accessed on 23 August 2021).
Hanahan, D.; Weinberg, R.A. Hallmarks of Cancer: The Next Generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [PubMed]
Shahi, P.K.; Pineda, I.F. Tumoral Angiogenesis: Review of the Literature. Cancer Investig. 2008, 26, 104–108. [Google Scholar] [CrossRef] [PubMed]
Dudek, A.; Gupta, K.; Ramakrishnan, S.; Mukhopadhyay, D. Tumor Angiogenesis. J. Oncol. 2010, 2010, 761671. [Google Scholar] [CrossRef] [PubMed]
Lugano, R.; Ramachandran, M.; Dimberg, A. Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cell. Mol. Life Sci. 2020, 77, 1745–1770. [Google Scholar] [CrossRef] [PubMed]
Paduch, R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell. Oncol. 2016, 39, 397–410. [Google Scholar] [CrossRef] [PubMed]
Karaman, S.; Detmar, M. Mechanisms of lymphatic metastasis. J. Clin. Investig. 2014, 124, 922–928. [Google Scholar] [CrossRef]
Brown, M.; Assen, F.P.; Leithner, A.; Abe, J.; Schachner, H.; Asfour, G.; Bago-Horvath, Z.; Stein, J.V.; Uhrin, P.; Sixt, M.; et al. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 2018, 359, 1408–1411. [Google Scholar] [CrossRef]
Pereira, E.R.; Kedrin, D.; Seano, G.; Gautier, O.; Meijer, E.F.J.; Jones, D.; Chin, S.-M.; Kitahara, S.; Bouta, E.M.; Chang, J.; et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 2018, 359, 1403–1407. [Google Scholar] [CrossRef]
Maj, E.; Papiernik, D.; Wietrzyk, J. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). Int. J. Oncol. 2016, 49, 1773–1784. [Google Scholar] [CrossRef]
Zirlik, K.; Duyster, J. Anti-Angiogenics: Current Situation and Future Perspectives. Oncol. Res. Treat. 2018, 41, 166–171. [Google Scholar] [CrossRef]
Brakenhielm, E.; González, A.; Díez, J. Role of Cardiac Lymphatics in Myocardial Edema and Fibrosis. J. Am. Coll. Cardiol. 2020, 76, 735–744. [Google Scholar] [CrossRef] [PubMed]
Houssari, M.; Dumesnil, A.; Tardif, V.; Kivelä, R.; Pizzinat, N.; Boukhalfa, I.; Godefroy, D.; Schapman, D.; Hemanthakumar, K.A.; Bizou, M.; et al. Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction. Arterioscler. Thromb. Vasc. Biol. 2020, 40, 1722–1737. [Google Scholar] [CrossRef]
Kim, H.; Kataru, R.; Koh, G.Y. Inflammation-associated lymphangiogenesis: A double-edged sword? J. Clin. Investig. 2014, 124, 936–942. [Google Scholar] [CrossRef]
Cimpean, A.M.; Raica, M. Lymphangiogenesis and Inflammation—Looking for the “Missing Pieces” of the Puzzle. Arch. Immunol. Ther. Exp. 2015, 63, 415–426. [Google Scholar] [CrossRef]
Paavonen, K.; Puolakkainen, P.; Jussila, L.; Jahkola, T.; Alitalo, K. Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing. Am. J. Pathol. 2000, 156, 1499–1504. [Google Scholar] [CrossRef]
Güç, E.; Briquez, P.S.; Foretay, D.; Fankhauser, M.; Hubbell, J.A.; Kilarski, W.W.; Swartz, M.A. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials 2017, 131, 160–175. [Google Scholar] [CrossRef]
Hoffmann, F.; Zhang, E.-P.; Mueller, A.; Schulte, F.; Foss, H.-D.; Franke, J.; Coupland, S.E. Contribution of lymphatic drainage system in corneal allograft rejection in mice. Graefe’s Arch. Clin. Exp. Ophthalmol. 2001, 239, 850–858. [Google Scholar] [CrossRef]
Zhong, W.; Montana, M.; Santosa, S.M.; Isjwara, I.D.; Huang, Y.-H.; Han, K.-Y.; O’Neil, C.; Wang, A.; Cortina, M.S.; de la Cruz, J.; et al. Angiogenesis and lymphangiogenesis in corneal transplantation—A review. Surv. Ophthalmol. 2018, 63, 453–479. [Google Scholar] [CrossRef]
Kinashi, H.; Ito, Y.; Sun, T.; Katsuno, T.; Takei, Y. Roles of the TGF-β–VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis. Int. J. Mol. Sci. 2018, 19, 2487. [Google Scholar] [CrossRef] [PubMed]
Honkonen, K.M.; Visuri, M.T.; Tervala, T.V.; Halonen, P.J.; Koivisto, M.; Lähteenvuo, M.; Alitalo, K.; Ylä-Herttuala, S.; Saaristo, A.M. Lymph Node Transfer and Perinodal Lymphatic Growth Factor Treatment for Lymphedema. Ann. Surg. 2013, 257, 961–967. [Google Scholar] [CrossRef] [PubMed]
Christiansen, A.; Detmar, M. Lymphangiogenesis and Cancer. Genes Cancer 2011, 2, 1146–1158. [Google Scholar] [CrossRef] [PubMed]
Xu, W.; Harris, N.R.; Caron, K.M. Lymphatic Vasculature: An Emerging Therapeutic Target and Drug Delivery Route. Annu. Rev. Med. 2021, 72, 167–182. [Google Scholar] [CrossRef]
Tammela, T.; Alitalo, K. Lymphangiogenesis: Molecular Mechanisms and Future Promise. Cell 2010, 140, 460–476. [Google Scholar] [CrossRef]
Stacker, S.A.; Achen, M.; Jussila, L.; Baldwin, M.E.; Alitalo, K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2002, 2, 573–583. [Google Scholar] [CrossRef]
Balsat, C.; Blacher, S.; Herfs, M.; Van de Velde, M.; Signolle, N.; Sauthier, P.; Pottier, C.; Gofflot, S.; De Cuypere, M.; Delvenne, P.; et al. A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer. OncoImmunology 2017, 6, e1265718. [Google Scholar] [CrossRef]
Naxerova, K.; Reiter, J.G.; Brachtel, E.; Lennerz, J.K.; van de Wetering, M.; Rowan, A.; Cai, T.; Clevers, H.; Swanton, C.; Nowak, M.A.; et al. Origins of lymphatic and distant metastases in human colorectal cancer. Science 2017, 357, 55–60. [Google Scholar] [CrossRef]
Ma, Q.; Dieterich, L.C.; Detmar, M. Multiple roles of lymphatic vessels in tumor progression. Curr. Opin. Immunol. 2018, 53, 7–12. [Google Scholar] [CrossRef]
Gillot, L.; Baudin, L.; Rouaud, L.; Kridelka, F.; Noël, A. The pre-metastatic niche in lymph nodes: Formation and characteristics. Cell. Mol. Life Sci. 2021, 78, 5987–6002. [Google Scholar] [CrossRef] [PubMed]
Cascinelli, N.; Morabito, A.; Santinami, M.; MacKie, R.; Belli, F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. Lancet 1998, 351, 793–796. [Google Scholar] [CrossRef]
Nathanson, S.D.; Kwon, D.; Kapke, A.; Alford, S.H.; Chitale, D. The Role of Lymph Node Metastasis in the Systemic Dissemination of Breast Cancer. Ann. Surg. Oncol. 2009, 16, 3396–3405. [Google Scholar] [CrossRef] [PubMed]
Dieterich, L.C.; Detmar, M. Tumor lymphangiogenesis and new drug development. Adv. Drug Deliv. Rev. 2016, 99, 148–160. [Google Scholar] [CrossRef] [PubMed]
Saif, M.W.; Knost, J.A.; Chiorean, E.G.; Kambhampati, S.R.P.; Yu, D.; Pytowski, B.; Qin, A.; Kauh, J.S.; O’Neil, B.H. Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer. Cancer Chemother. Pharmacol. 2016, 78, 815–824. [Google Scholar] [CrossRef]
Torgbenu, E.; Luckett, T.; Buhagiar, M.A.; Chang, S.; Phillips, J. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis. BMC Cancer 2020, 20, 604. [Google Scholar] [CrossRef]
Manrique, O.J.; Bustos, S.S.; Ciudad, P.; Adabi, K.; Chen, W.F.; Forte, A.J.; Cheville, A.L.; Jakub, J.W.; McLaughlin, S.A.; Chen, H.-C. Overview of Lymphedema for Physicians and Other Clinicians: A Review of Fundamental Concepts. Mayo Clin. Proc. 2020. [Google Scholar] [CrossRef]
Kayiran, O.; De La Cruz, C.; Tane, K.; Soran, A. Lymphedema: From diagnosis to treatment. Turk. J. Surg. 2017, 33, 51–57. [Google Scholar] [CrossRef]
Kato, S.; Shimoda, H.; Ji, R.-C.; Miura, M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat. Sci. Int. 2006, 81, 71–83. [Google Scholar] [CrossRef] [PubMed]
Baluk, P.; McDonald, D.M. Markers for Microscopic Imaging of Lymphangiogenesis and Angiogenesis. Ann. N. Y. Acad. Sci. 2008, 1131, 1–12. [Google Scholar] [CrossRef] [PubMed]
Hirakawa, S.; Hong, Y.-K.; Harvey, N.; Schacht, V.; Matsuda, K.; Libermann, T.; Detmar, M. Identification of Vascular Lineage-Specific Genes by Transcriptional Profiling of Isolated Blood Vascular and Lymphatic Endothelial Cells. Am. J. Pathol. 2003, 162, 575–586. [Google Scholar] [CrossRef]
Bruyère, F.; Noël, A. Lymphangiogenesis: In vitro and in vivo models. FASEB J. 2010, 24, 8–21. [Google Scholar] [CrossRef]
Altrock, P.; Liu, L.L.; Michor, F. The mathematics of cancer: Integrating quantitative models. Nat. Rev. Cancer 2015, 15, 730–745. [Google Scholar] [CrossRef] [PubMed]
Scianna, M.; Bell, C.; Preziosi, L. A review of mathematical models for the formation of vascular networks. J. Theor. Biol. 2013, 333, 174–209. [Google Scholar] [CrossRef] [PubMed]
Jean-Quartier, C.; Jeanquartier, F.; Jurisica, I.; Holzinger, A. In silico cancer research towards 3R. BMC Cancer 2018, 18, 408. [Google Scholar] [CrossRef]
Viceconti, M.; Henney, A.; Morley-Fletcher, E. In silico clinical trials: How computer simulation will transform the biomedical industry. Int. J. Clin. Trials 2016, 3, 37–46. [Google Scholar] [CrossRef]
Stacker, S.A.; Williams, S.P.; Karnezis, T.; Shayan, R.; Fox, S.B.; Achen, M.G. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer 2014, 14, 159–172. [Google Scholar] [CrossRef]
Karpanen, T.; Alitalo, K. Molecular Biology and Pathology of Lymphangiogenesis. Annu. Rev. Pathol. Mech. Dis. 2008, 3, 367–397. [Google Scholar] [CrossRef]
Mumprecht, V.; Detmar, M. Lymphangiogenesis and cancer metastasis. J. Cell. Mol. Med. 2009, 13, 1405–1416. [Google Scholar] [CrossRef] [PubMed]
Secker, G.A.; Harvey, N.L. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels. Dev. Dyn. 2015, 244, 323–331. [Google Scholar] [CrossRef] [PubMed]
Zheng, W.; Aspelund, A.; Alitalo, K. Lymphangiogenic factors, mechanisms, and applications. J. Clin. Investig. 2014, 124, 878–887. [Google Scholar] [CrossRef] [PubMed]
Morfoisse, F.; Noel, A. Lymphatic and blood systems: Identical or fraternal twins? Int. J. Biochem. Cell Biol. 2019, 114, 105562. [Google Scholar] [CrossRef]
Durré, T.; Morfoisse, F.; Erpicum, C.; Ebroin, M.; Blacher, S.; García-Caballero, M.; Deroanne, C.; Louis, T.; Balsat, C.; Van De Velde, M.; et al. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nat. Commun 2018, 9, 5178. [Google Scholar] [CrossRef]
Folpe, A.L.; Veikkola, T.; Valtola, R.; Weiss, S.W. Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi’s Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas. Mod. Pathol. 2000, 13, 180–185. [Google Scholar] [CrossRef]
Jackson, D.G. Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking. Matrix Biol. 2019, 78–79, 219–235. [Google Scholar] [CrossRef]
Breiteneder-Geleff, S.; Soleiman, A.; Kowalski, H.; Horvat, R.; Amann, G.; Kriehuber, E.; Diem, K.; Weninger, W.; Tschachler, E.; Alitalo, K.; et al. Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries: Podoplanin as a Specific Marker for Lymphatic Endothelium. Am. J. Pathol. 1999, 154, 385–394. [Google Scholar] [CrossRef]
Hong, Y.-K.; Harvey, N.; Noh, Y.-H.; Schacht, V.; Hirakawa, S.; Detmar, M.; Oliver, G. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 2002, 225, 351–357. [Google Scholar] [CrossRef]
Fisher, B.; Jeong, J.; Anderson, S.; Bryant, J.; Fisher, E.R.; Wolmark, N. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation. N. Engl. J. Med. 2002, 347, 567–575. [Google Scholar] [CrossRef]
Cady, B. Regional Lymph Node Metastases; a Singular Manifestation of the Process of Clinical Metastases in Cancer: Contemporary Animal Research and Clinical Reports Suggest Unifying Concepts. Ann. Surg. Oncol. 2007, 14, 1790–1800. [Google Scholar] [CrossRef] [PubMed]
Jain, R.K. Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia. Cancer Cell 2014, 26, 605–622. [Google Scholar] [CrossRef] [PubMed]
Gnepp, D.R.; Chandler, W. Tissue culture of human and canine thoracic duct endothelium. In Vitro Cell. Dev. Biol. 1985, 21, 200–206. [Google Scholar] [CrossRef] [PubMed]
Whitehurst, B.; Eversgerd, C.; Flister, M.; Bivens, C.M.; Pickett, B.; Zawieja, D.C.; Ran, S. Molecular Profile and Proliferative Responses of Rat Lymphatic Endothelial Cells in Culture. Lymphat. Res. Biol. 2006, 4, 119–142. [Google Scholar] [CrossRef]
Staton, C.A.; Reed, M.W.R.; Brown, N.J. A critical analysis of current in vitro and in vivo angiogenesis assays. Int. J. Exp. Pathol. 2009, 90, 195–221. [Google Scholar] [CrossRef]
García-Caballero, M.; Paupert, J.; Blacher, S.; Van De Velde, M.; Quesada, A.R.; Medina, M.A.; Noël, A. Targeting VEGFR-3/-2 signaling pathways with AD0157: A potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases. J. Hematol. Oncol. 2017, 10, 122. [Google Scholar] [CrossRef]
Williams, S.P.; Gould, C.M.; Nowell, C.; Karnezis, T.; Achen, M.; Simpson, K.; Stacker, S. Systematic high-content genome-wide RNAi screens of endothelial cell migration and morphology. Sci. Data 2017, 4, 170009. [Google Scholar] [CrossRef]
Gibot, L.; Galbraith, T.; Kloos, B.; Das, S.; Lacroix, D.A.; Auger, F.A.; Skobe, M. Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis. Biomaterials 2016, 78, 129–139. [Google Scholar] [CrossRef]
Bruyère, F.; Melen-Lamalle, L.; Blacher, S.; Roland, G.; Thiry, M.; Moons, L.; Frankenne, F.; Carmeliet, P.; Alitalo, K.; Libert, C.; et al. Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 2008, 5, 431–437. [Google Scholar] [CrossRef]
Henderson, A.R.; Choi, H.; Lee, E. Blood and Lymphatic Vasculatures On-Chip Platforms and Their Applications for Organ-Specific In Vitro Modeling. Micromachines 2020, 11, 147. [Google Scholar] [CrossRef]
Martinez-Corral, I.; Makinen, T. Regulation of lymphatic vascular morphogenesis: Implications for pathological (tumor) lymphangiogenesis. Exp. Cell Res. 2013, 319, 1618–1625. [Google Scholar] [CrossRef] [PubMed]
Ng, C.P.; Helm, C.-L.E.; Swartz, M.A. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 2004, 68, 258–264. [Google Scholar] [CrossRef] [PubMed]
Boardman, K.C.; Swartz, M.A. Interstitial Flow as a Guide for Lymphangiogenesis. Circ. Res. 2003, 92, 801–808. [Google Scholar] [CrossRef] [PubMed]
Helm, C.-L.E.; Zisch, A.; Swartz, M.A. Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow. Biotechnol. Bioeng. 2007, 96, 167–176. [Google Scholar] [CrossRef]
Pisano, M.; Triacca, V.; Barbee, K.A.; Swartz, M.A. An in vitro model of the tumor–lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. Integr. Biol. 2015, 7, 525–533. [Google Scholar] [CrossRef]
Marino, D.; Luginbühl, J.; Scola, S.; Meuli, M.; Reichmann, E. Bioengineering Dermo-Epidermal Skin Grafts with Blood and Lymphatic Capillaries. Sci. Transl. Med. 2014, 6, 221ra14. [Google Scholar] [CrossRef]
Frenkel, N.; Poghosyan, S.; Alarcón, C.R.; García, S.B.; Queiroz, K.; van den Bent, L.; Laoukili, J.; Rinkes, I.B.; Vulto, P.; Kranenburg, O.; et al. Long-Lived Human Lymphatic Endothelial Cells to Study Lymphatic Biology and Lymphatic Vessel/Tumor Coculture in a 3D Microfluidic Model. ACS Biomater. Sci. Eng. 2021, 7, 3030–3042. [Google Scholar] [CrossRef]
Kim, S.; Chung, M.; Jeon, N.L. Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro. Biomaterials 2016, 78, 115–128. [Google Scholar] [CrossRef]
Liu, T.; Liu, Q.; Anaya, I.; Huang, D.; Kong, W.; Mille, L.S.; Zhang, Y.S. Investigating lymphangiogenesis in a sacrificially bioprinted volumetric model of breast tumor tissue. Methods 2021, 190, 72–79. [Google Scholar] [CrossRef]
Gibot, L.; Galbraith, T.; Bourland, J.; Rogic, A.; Skobe, M.; Auger, F.A. Tissue-engineered 3D human lymphatic microvascular network for in vitro studies of lymphangiogenesis. Nat. Protoc. 2017, 12, 1077–1088. [Google Scholar] [CrossRef]
Tronolone, J.J.; Jain, A. Engineering New Microvascular Networks On-Chip: Ingredients, Assembly, and Best Practices. Adv. Funct. Mater. 2021, 31, 2007199. [Google Scholar] [CrossRef] [PubMed]
Landau, S.; Newman, A.; Edri, S.; Michael, I.; Ben-Shaul, S.; Shandalov, Y.; Ben-Arye, T.; Kaur, P.; Zheng, M.H.; Levenberg, S. Investigating lymphangiogenesis in vitro and in vivo using engineered human lymphatic vessel networks. Proc. Natl. Acad. Sci. USA 2021, 118, e2101931118. [Google Scholar] [CrossRef] [PubMed]
Li, Z.; Zheng, W.; Wang, H.; Cheng, Y.; Fang, Y.; Wu, F.; Sun, G.; Sun, G.; Lv, C.; Hui, B. Application of Animal Models in Cancer Research: Recent Progress and Future Prospects. Cancer Manag. Res. 2021, 13, 2455–2475. [Google Scholar] [CrossRef]
Burton, J.B.; Priceman, S.J.; Sung, J.L.; Brakenhielm, E.; An, D.S.; Pytowski, B.; Alitalo, K.; Wu, L. Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis. Cancer Res. 2008, 68, 7828–7837. [Google Scholar] [CrossRef]
Holopainen, T.; Saharinen, P.; D’Amico, G.; Lampinen, A.; Eklund, L.; Sormunen, R.; Anisimov, A.; Zarkada, G.; Lohela, M.; Heloterä, H.; et al. Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis. J. Natl. Cancer Inst. 2012, 104, 461–475. [Google Scholar] [CrossRef]
Matsui, J.; Funahashi, Y.; Uenaka, T.; Watanabe, T.; Tsuruoka, A.; Asada, M. Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase. Clin. Cancer Res. 2008, 14, 5459–5465. [Google Scholar] [CrossRef]
Alitalo, A.; Detmar, M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 2012, 31, 4499–4508. [Google Scholar] [CrossRef]
Schulz, M.M.P.; Reisen, F.; Zgraggen, S.; Fischer, S.; Yuen, D.; Kang, G.J.; Chen, L.; Schneider, G.; Detmar, M. Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis. Proc. Natl. Acad. Sci. USA 2012, 109, E2665–E2674. [Google Scholar] [CrossRef]
Kawakami, M.; Yanai, Y.; Hata, F.; Hirata, K. Vascular Endothelial Growth Factor C Promotes Lymph Node Metastasis in a Rectal Cancer Orthotopic Model. Surg. Today 2005, 35, 131–138. [Google Scholar] [CrossRef]
Shin, W.S.; Rockson, S.G. Animal Models for the Molecular and Mechanistic Study of Lymphatic Biology and Disease. Ann. N. Y. Acad. Sci. 2008, 1131, 50–74. [Google Scholar] [CrossRef] [PubMed]
Mattila, M.M.-T.; Ruohola, J.K.; Karpanen, T.; Jackson, D.G.; Alitalo, K.; Härkönen, P.L. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer 2002, 98, 946–951. [Google Scholar] [CrossRef] [PubMed]
Skobe, M.; Hawighorst, T.; Jackson, D.G.; Prevo, R.; Janes, L.; Velasco, P.; Riccardi, L.; Alitalo, K.; Claffey, K.; Detmar, M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7, 192–198. [Google Scholar] [CrossRef] [PubMed]
Stacker, S.A.; Caesar, C.; Baldwin, M.E.; Thornton, G.E.; Williams, R.A.; Prevo, R.; Jackson, D.G.; Nishikawa, S.-I.; Kubo, H.; Achen, M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 2001, 7, 186–191. [Google Scholar] [CrossRef]
Karnezis, T.; Shayan, R.; Caesar, C.; Roufail, S.; Harris, N.C.; Ardipradja, K.; Zhang, Y.F.; Williams, S.; Farnsworth, R.; Chai, M.G.; et al. VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium. Cancer Cell 2012, 21, 181–195. [Google Scholar] [CrossRef]
He, Y.; Rajantie, I.; Pajusola, K.; Jeltsch, M.; Holopainen, T.; Ylä-Herttuala, S.; Harding, T.; Jooss, K.; Takahashi, T.; Alitalo, K. Vascular Endothelial Cell Growth Factor Receptor 3–Mediated Activation of Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels. Cancer Res. 2005, 65, 4739–4746. [Google Scholar] [CrossRef]
Yang, H.; Kim, C.; Kim, M.-J.; Schwendener, R.A.; Alitalo, K.; Heston, W.; Kim, I.; Kim, W.-J.; Koh, G.Y. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol. Cancer 2011, 10, 36. [Google Scholar] [CrossRef]
Shibata, M.; Shibata, E.; Tanaka, Y.; Shiraoka, C.; Kondo, Y. Soluble Vegfr3 gene therapy suppresses multi-organ metastasis in a mouse mammary cancer model. Cancer Sci. 2020, 111, 2837–2849. [Google Scholar] [CrossRef]
Abéngozar, M.A.; De Frutos, S.; Ferreiro, S.; Soriano, J.; Perez-Martinez, M.; Olmeda, D.; Marenchino, M.; Cañamero, M.; Ortega, S.; Megias, D.; et al. Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood 2012, 119, 4565–4576. [Google Scholar] [CrossRef]
Xu, Y.; Yuan, L.; Mak, J.; Pardanaud, L.; Caunt, M.; Kasman, I.; Larrivée, B.; Del Toro, R.; Suchting, S.; Medvinsky, A.; et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 2010, 188, 115–130. [Google Scholar] [CrossRef] [PubMed]
Caunt, M.; Mak, J.; Liang, W.-C.; Stawicki, S.; Pan, Q.; Tong, R.K.; Kowalski, J.; Ho, C.; Reslan, H.B.; Ross, J.; et al. Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis. Cancer Cell 2008, 13, 331–342. [Google Scholar] [CrossRef] [PubMed]
Astin, J.; Jamieson, S.M.; Eng, T.C.; Flores, M.V.; Misa, J.P.; Chien, A.; Crosier, K.E.; Crosier, P.S. An In Vivo Antilymphatic Screen in Zebrafish Identifies Novel Inhibitors of Mammalian Lymphangiogenesis and Lymphatic-Mediated Metastasis. Mol. Cancer Ther. 2014, 13, 2450–2462. [Google Scholar] [CrossRef] [PubMed]
Zhang, Y.; Yang, X.; Liu, H.; Cai, M.; Shentu, Y. Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC. J. Cancer 2020, 11, 241–250. [Google Scholar] [CrossRef] [PubMed]
Eklund, L.; Bry, M.; Alitalo, K. Mouse models for studying angiogenesis and lymphangiogenesis in cancer. Mol. Oncol. 2013, 7, 259–282. [Google Scholar] [CrossRef] [PubMed]
Van de Velde, M.; García-Caballero, M.; Durré, T.; Kridelka, F.; Noël, A. Ear Sponge Assay: A Method to Investigate Angiogenesis and Lymphangiogenesis in Mice. In Proteases and Cancer: Methods and Protocols; Springer: Berlin/Heidelberg, Germany, 2018; Volume 1731, pp. 223–233. [Google Scholar] [CrossRef]
García-Caballero, M.; Van De Velde, M.; Blacher, S.; Lambert, V.; Balsat, C.; Erpicum, C.; Durré, T.; Kridelka, F.; Noel, A. Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay. Sci. Rep. 2017, 7, 41494. [Google Scholar] [CrossRef]
Veldman, M.B.; Lin, S. Zebrafish as a Developmental Model Organism for Pedriatric Research. Pediatr. Res. 2008, 64, 470–476. [Google Scholar] [CrossRef]
Cultrone, D.; Zammit, N.W.; Self, E.; Postert, B.; Han, J.Z.R.; Bailey, J.; Warren, J.; Croucher, D.R.; Kikuchi, K.; Bogdanovic, O.; et al. A zebrafish functional genomics model to investigate the role of human A20 variants in vivo. Sci. Rep. 2020, 10, 19085. [Google Scholar] [CrossRef]
Chen, X.; Li, Y.; Yao, T.; Jia, R. Benefits of Zebrafish Xenograft Models in Cancer Research. Front. Cell Dev. Biol. 2021, 9, 94. [Google Scholar] [CrossRef]
Gamble, J.; Elson, D.; Greenwood, J.; Tanguay, R.; Kolluri, S. The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics. Biology 2021, 10, 252. [Google Scholar] [CrossRef] [PubMed]
Willemsen, R.; van’t Padje, S.; van Swieten, J.C.; Oostra, B.A. Zebrafish (Danio rerio) as a Model Organism for Dementia. In Animal Models of Dementia; Springer: Berlin/Heidelberg, Germany, 2011; Volume 48, pp. 255–269. [Google Scholar] [CrossRef]
Hason, M.; Bartůněk, P. Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate. Genes 2019, 10, 935. [Google Scholar] [CrossRef] [PubMed]
Yan, C.; Brunson, D.; Tang, Q.; Do, D.; Iftimia, N.A.; Moore, J.C.; Hayes, M.N.; Welker, A.M.; Garcia, E.G.; Dubash, T.D.; et al. Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish. Cell 2019, 177, 1903–1914.e14. [Google Scholar] [CrossRef] [PubMed]
White, R.M.; Sessa, A.; Burke, C.; Bowman, T.; LeBlanc, J.; Ceol, C.; Bourque, C.; Dovey, M.; Goessling, W.; Burns, C.E.; et al. Transparent Adult Zebrafish as a Tool for In Vivo Transplantation Analysis. Cell Stem Cell 2008, 2, 183–189. [Google Scholar] [CrossRef] [PubMed]
Hogan, B.M.; Schulte-Merker, S. How to Plumb a Pisces: Understanding Vascular Development and Disease Using Zebrafish Embryos. Dev. Cell 2017, 42, 567–583. [Google Scholar] [CrossRef] [PubMed]
Hyenne, V.; Ghoroghi, S.; Collot, M.; Bons, J.; Follain, G.; Harlepp, S.; Mary, B.; Bauer, J.; Mercier, L.; Busnelli, I.; et al. Studying the Fate of Tumor Extracellular Vesicles at High Spatiotemporal Resolution Using the Zebrafish Embryo. Dev. Cell 2019, 48, 554–572.e7. [Google Scholar] [CrossRef]
Nakajima, H.; Chiba, A.; Fukumoto, M.; Morooka, N.; Mochizuki, N. Zebrafish Vascular Development: General and Tissue-Specific Regulation. J. Lipid Atheroscler. 2021, 10, 145–159. [Google Scholar] [CrossRef]
Okuda, K.S.; Lee, H.M.; Velaithan, V.; Ng, M.F.; Patel, V. Utilizing Zebrafish to Identify Anti-(Lymph)Angiogenic Compounds for Cancer Treatment: Promise and Future Challenges. Microcirculation 2016, 23, 389–405. [Google Scholar] [CrossRef]
Chávez, M.N.; Aedo, G.; Fierro, F.; Allende, M.L.; Egaña, J.T. Zebrafish as an Emerging Model Organism to Study Angiogenesis in Development and Regeneration. Front. Physiol. 2016, 7, 56. [Google Scholar] [CrossRef]
Tulotta, C.; He, S.; van der Ent, W.; Chen, L.; Groenewoud, A.; Spaink, H.P.; Snaar-Jagalska, B.E. Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model. In Cancer and Zebrafish: Mechanisms, Techniques, and Models; Springer: Berlin/Heidelberg, Germany, 2016; Volume 916, pp. 239–263. [Google Scholar] [CrossRef]
Astin, J.W.; Crosier, P.S. Lymphatics, Cancer and Zebrafish. In Cancer and Zebrafish: Mechanisms, Techniques, and Models; Springer: Berlin/Heidelberg, Germany, 2016; pp. 199–218. [Google Scholar] [CrossRef]
Küchler, A.M.; Gjini, E.; Peterson-Maduro, J.; Cancilla, B.; Wolburg, H.; Schulte-Merker, S. Development of the Zebrafish Lymphatic System Requires Vegfc Signaling. Curr. Biol. 2006, 16, 1244–1248. [Google Scholar] [CrossRef] [PubMed]
Shin, M.; Male, I.; Beane, T.J.; Villefranc, J.A.; Kok, F.O.; Zhu, L.J.; Lawson, N.D. Vegfc acts through ERK to induce sprouting and differentiation of trunk lymphatic progenitors. Development 2016, 143, 3785–3795. [Google Scholar] [CrossRef] [PubMed]
Bower, N.I.; Vogrin, A.J.; Le Guen, L.; Chen, H.; Stacker, S.; Achen, M.G.; Hogan, B.M. Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development. Development 2017, 144, 507–518. [Google Scholar] [CrossRef] [PubMed]
Vivien, C.J.; Pichol-Thievend, C.; Sim, C.B.; Smith, J.B.; Bower, N.I.; Hogan, B.M.; Hudson, J.E.; Francois, M.; Porrello, E.R. Vegfc/d-dependent regulation of the lymphatic vasculature during cardiac regeneration is influenced by injury context. npj Regen. Med. 2019, 4, 18. [Google Scholar] [CrossRef]
Grimm, L.; Nakajima, H.; Chaudhury, S.; Bower, N.; Okuda, K.S.; Cox, A.G.; Harvey, N.L.; Koltowska, K.; Mochizuki, N.; Hogan, B.M. Yap1 promotes sprouting and proliferation of lymphatic progenitors downstream of Vegfc in the zebrafish trunk. eLife 2019, 8, e42881. [Google Scholar] [CrossRef] [PubMed]
Okuda, K.; Ng, M.; Ruslan, N.; Bower, N.; Song, D.; Chen, H.; Baek, S.; Crosier, P.; Koltowska, K.; Astin, J.; et al. 3,4-Difluorobenzocurcumin Inhibits Vegfc-Vegfr3-Erk Signalling to Block Developmental Lymphangiogenesis in Zebrafish. Pharmaceuticals 2021, 14, 614. [Google Scholar] [CrossRef]
Hong, M.; Jung, E.; Yang, S.; Jung, W.; Seong, Y.J.; Park, E.; Bramos, A.; Kim, K.E.; Lee, S.; Daghlian, G.; et al. Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells. PLoS ONE 2016, 11, e0157126. [Google Scholar] [CrossRef]
Hägerling, R.; Pollmann, C.; Kremer, L.; Andresen, V.; Kiefer, F. Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochem. Soc. Trans. 2011, 39, 1674–1681. [Google Scholar] [CrossRef]
Choi, I.; Chung, H.K.; Ramu, S.; Lee, H.N.; Kim, K.E.; Lee, S.; Yoo, J.; Choi, D.; Lee, Y.S.; Aguilar, B.; et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 2011, 117, 362–365. [Google Scholar] [CrossRef]
Jung, E.; Gardner, D.; Choi, D.; Park, E.; Seong, Y.J.; Yang, S.; Castorena-Gonzalez, J.; Louveau, A.; Zhou, Z.; Lee, G.K.; et al. Development and Characterization of A Novel Prox1-EGFP Lymphatic and Schlemm’s Canal Reporter Rat. Sci. Rep. 2017, 7, 5577. [Google Scholar] [CrossRef] [PubMed]
Olmeda, D.; Cerezo-Wallis, D.; Riveiro-Falkenbach, E.; Pennacchi, P.C.; Contreras-Alcalde, M.; Ibarz, N.; Cifdaloz, M.; Catena, X.; Calvo, T.G.; Cañón, E.; et al. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature 2017, 546, 676–680. [Google Scholar] [CrossRef] [PubMed]
Doh, S.J.; Yamakawa, M.; Santosa, S.M.; Montana, M.; Guo, K.; Sauer, J.R.; Curran, N.; Han, K.-Y.; Yu, C.; Ema, M.; et al. Fluorescent Reporter Transgenic Mice for In Vivo Live Imaging of Angiogenesis and Lymphangiogenesis. Angiogenesis 2018, 176, 677–698. [Google Scholar] [CrossRef] [PubMed]
Castranova, D.; Samasa, B.; Galanternik, M.V.; Jung, H.M.; Pham, V.N.; Weinstein, B.M. Live Imaging of Intracranial Lymphatics in the Zebrafish. Circ. Res. 2021, 128, 42–58. [Google Scholar] [CrossRef]
Hoffman, S.J.; Psaltis, P.J.; Clark, K.J.; Spoon, D.B.; Chue, C.D.; Ekker, S.C.; Simari, R.D. An In Vivo Method to Quantify Lymphangiogenesis in Zebrafish. PLoS ONE 2012, 7, e45240. [Google Scholar] [CrossRef]
Yaniv, K.; Isogai, S.; Castranova, D.; Dye, L.; Hitomi, J.; Weinstein, B.M. Live imaging of lymphatic development in the zebrafish. Nat. Med. 2006, 12, 711–716. [Google Scholar] [CrossRef]
Miller, J.C.; Pien, H.H.; Sahani, D.; Sorensen, A.G.; Thrall, J.H. Imaging Angiogenesis: Applications and Potential for Drug Development. J. Natl. Cancer Inst. 2005, 97, 172–187. [Google Scholar] [CrossRef]
Hackethal, A.; Hirschburger, M.; Eicker, S.O.; Mücke, T.; Lindner, C.; Buchweitz, O. Role of Indocyanine Green in Fluorescence Imaging with Near-Infrared Light to Identify Sentinel Lymph Nodes, Lymphatic Vessels and Pathways Prior to Surgery—A Critical Evaluation of Options. Geburtshilfe Frauenheilkd. 2018, 78, 54–62. [Google Scholar] [CrossRef]
Suami, H.; Heydon-White, A.; Mackie, H.; Czerniec, S.; Koelmeyer, L.; Boyages, J. A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema. BMC Cancer 2019, 19, 985. [Google Scholar] [CrossRef] [PubMed]
Hall, M.A.; Robinson, H.; Chan, W.; Sevick-Muraca, E.M. Detection of lymphangiogenesis by near-infrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model. Wound Repair Regen. 2013, 21, 604–615. [Google Scholar] [CrossRef] [PubMed]
Zhou, Q.; Wood, R.; Schwarz, E.M.; Wang, Y.-J.; Xing, L. Near infrared lymphatic imaging demonstrates the dynamics of lymph flow and lymphangiogenesis during the acute vs. chronic phases of arthritis in mice. Arthritis Rheum. 2010, 62, 1881–1889. [Google Scholar] [CrossRef] [PubMed]
Mumprecht, V.; Honer, M.; Vigl, B.; Proulx, S.; Trachsel, E.; Kaspar, M.; Banziger-Tobler, N.E.; Schibli, R.; Neri, D.; Detmar, M. In vivo Imaging of Inflammation- and Tumor-Induced Lymph Node Lymphangiogenesis by Immuno–Positron Emission Tomography. Cancer Res. 2010, 70, 8842–8851. [Google Scholar] [CrossRef]
Sleeman, J.P. The lymph node pre-metastatic niche. J. Mol. Med. 2015, 93, 1173–1184. [Google Scholar] [CrossRef]
Yang, H.; Zou, L.; Zhang, S.; Gong, M.; Zhang, D.; Qi, Y.; Zhou, S.; Diao, X. Feasibility of MR imaging in evaluating breast cancer lymphangiogenesis using Polyethylene glycol-GoldMag nanoparticles. Clin. Radiol. 2013, 68, 1233–1240. [Google Scholar] [CrossRef]
Polomska, A.K.; Proulx, S.T. Imaging technology of the lymphatic system. Adv. Drug Deliv. Rev. 2021, 170, 294–311. [Google Scholar] [CrossRef]
Elshikh, M.; Moawad, A.W.; Salem, U.; Klimkowski, S.P.; Hassan, T.; Korivi, B.R.; Jensen, C.T.; Javadi, S.; Elsayes, K.M. Oncologic Imaging of the Lymphatic System: Current Perspective with Multi-Modality Imaging and New Horizon. Cancers 2021, 13, 4554. [Google Scholar] [CrossRef] [PubMed]
Pathmanathan, P.; Gray, R.A.; Romero, V.J.; Morrison, T.M. Applicability Analysis of Validation Evidence for Biomedical Computational Models. J. Verif. Valid. Uncert. Quantif. 2017, 2, 021005. [Google Scholar] [CrossRef]
ASME. Assessing Credibility of Computational Modeling through Verification and Validation: Application to Medical Devices; ASME: New York, NY, USA, 2018. [Google Scholar]
Bekisz, S.; Geris, L. Cancer modeling: From mechanistic to data-driven approaches, and from fundamental insights to clinical applications. J. Comput. Sci. 2020, 46, 101198. [Google Scholar] [CrossRef]
Lesage, R.; Kerkhofs, J.; Geris, L. Computational Modeling and Reverse Engineering to Reveal Dominant Regulatory Interactions Controlling Osteochondral Differentiation: Potential for Regenerative Medicine. Front. Bioeng. Biotechnol. 2018, 6, 165. [Google Scholar] [CrossRef]
Torres, N.V.; Santos, G. The (Mathematical) Modeling Process in Biosciences. Front. Genet. 2015, 6, 354. [Google Scholar] [CrossRef]
Motta, S.; Pappalardo, F. Mathematical modeling of biological systems. Brief. Bioinform. 2013, 14, 411–422. [Google Scholar] [CrossRef]
Kuemmel, C.; Yang, Y.; Zhang, X.; Florian, J.; Zhu, H.; Tegenge, M.; Huang, S.; Wang, Y.; Morrison, T.; Zineh, I. Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation. CPT Pharmacomet. Syst. Pharmacol. 2020, 9, 21–28. [Google Scholar] [CrossRef]
Peirce, S.M. Computational and Mathematical Modeling of Angiogenesis. Microcirculation 2008, 15, 739–751. [Google Scholar] [CrossRef]
Heck, T.; Vaeyens, M.M.; Van Oosterwyck, H. Computational Models of Sprouting Angiogenesis and Cell Migration: Towards Multiscale Mechanochemical Models of Angiogenesis. Math. Model. Nat. Phenom. 2015, 10, 108–141. [Google Scholar] [CrossRef]
Chaplain, M.A.J. Mathematical Modelling of Angiogenesis. J. Neuro-Oncol. 2000, 50, 37–51. [Google Scholar] [CrossRef]
Levine, H.A.; Nilsen-Hamilton, M. Angiogenesis—A Biochemical/Mathematical Perspective. In Tutorials in Mathematical Biosciences III: Cell Cycle, Proliferation, and Cancer; Springer: Berlin/Heidelberg, Germany, 2005; pp. 23–76. [Google Scholar] [CrossRef]
Levine, H.; Sleeman, B. Modelling Tumour-Induced Angiogenesis. In Cancer Modelling and Simulation; CRC Press: Boca Raton, FL, USA, 2003. [Google Scholar] [CrossRef]
Qutub, A.A.; Mac Gabhann, F.; Karagiannis, E.; Vempati, P.; Popel, A. Multiscale models of angiogenesis. IEEE Eng. Med. Biol. Mag. 2009, 28, 14–31. [Google Scholar] [CrossRef]
Suzuki, T.; Minerva, D.; Nishiyama, K.; Koshikawa, N.; Chaplain, M. Study on the tumor-induced angiogenesis using mathematical models. Cancer Sci. 2018, 109, 15–23. [Google Scholar] [CrossRef] [PubMed]
Lowengrub, J.S.; Frieboes, H.B.; Jin, F.; Chuang, Y.-L.; Li, X.; Macklin, P.; Wise, S.M.; Cristini, V. Nonlinear modelling of cancer: Bridging the gap between cells and tumours. Nonlinearity 2010, 23, R1. [Google Scholar] [CrossRef] [PubMed]
Reddy, N.; Patel, K. A mathematical model of flow through the terminal lymphatics. Med Eng. Phys. 1995, 17, 134–140. [Google Scholar] [CrossRef]
Reddy, N.P.; Krouskop, T.A.; Newell, P.H. A computer model of the lymphatic system. Comput. Biol. Med. 1977, 7, 181–197. [Google Scholar] [CrossRef]
Reddy, N.P.; Krouskop, T.A.; Newell, J.P.H. Biomechanics of a Lymphatic Vessel. J. Vasc. Res. 1975, 12, 261–278. [Google Scholar] [CrossRef]
Elhay, S.; Casley-Smith, J. Mathematical model of the initial lymphatics. Microvasc. Res. 1976, 12, 121–140. [Google Scholar] [CrossRef]
Macdonald, A.J.; Arkill, K.; Tabor, G.; McHale, N.G.; Winlove, C.P. Modeling flow in collecting lymphatic vessels: One-dimensional flow through a series of contractile elements. Am. J. Physiol. Circ. Physiol. 2008, 295, H305–H313. [Google Scholar] [CrossRef]
Roose, T.; Tabor, G. Multiscale Modelling of Lymphatic Drainage. In Multiscale Computer Modeling in Biomechanics and Biomedical Engineering; Springer: Berlin/Heidelberg, Germany, 2012; pp. 149–176. [Google Scholar] [CrossRef]
Mozokhina, A.; Savinkov, R. Mathematical Modelling of the Structure and Function of the Lymphatic System. Mathematics 2020, 8, 1467. [Google Scholar] [CrossRef]
Tretyakova, R.M.; Lobov, G.I.; Bocharov, G.A. Modelling lymph flow in the lymphatic system: From 0D to 1D spatial resolution. Math. Model. Nat. Phenom. 2018, 13, 45. [Google Scholar] [CrossRef]
Cooper, L.J.; Heppell, J.; Clough, G.F.; Ganapathisubramani, B.; Roose, T. An Image-Based Model of Fluid Flow Through Lymph Nodes. Bull. Math. Biol. 2016, 78, 52–71. [Google Scholar] [CrossRef] [PubMed]
Ikhimwin, B.O.; Bertram, C.D.; Jamalian, S.; Macaskill, C. A computational model of a network of initial lymphatics and pre-collectors with permeable interstitium. Biomech. Model. Mechanobiol. 2020, 19, 661–676. [Google Scholar] [CrossRef] [PubMed]
Friedman, A.; Lolas, G. Analysis of a mathematical model of tumor lymphangiogenesis. Math. Model. Methods Appl. Sci. 2005, 15, 95–107. [Google Scholar] [CrossRef]
Pepper, M.S.; Lolas, G. The Lymphatic Vascular System in Lymphangiogenesis Invasion and Metastasis A Mathematical Approach. In Selected Topics in Cancer Modeling; Birkhäuser: Boston, MA, USA, 2008; pp. 1–22. [Google Scholar] [CrossRef]
Lolas, G.; Jensen, L.; Bourantas, G.C.; Tsikourkitoudi, V.; Syrigos, K. Modeling Proteolytically Driven Tumor Lymphangiogenesis. In Systems Biology of Tumor Microenvironment: Quantitative Modeling and Simulations; Springer: Berlin/Heidelberg, Germany, 2016; Volume 936, pp. 107–136. [Google Scholar] [CrossRef]
Novkovic, M.; Onder, L.; Cheng, H.-W.; Bocharov, G.; Ludewig, B. Integrative Computational Modeling of the Lymph Node Stromal Cell Landscape. Front. Immunol. 2018, 9, 2428. [Google Scholar] [CrossRef]
Jafarnejad, M.; Zawieja, D.C.; Brook, B.S.; Nibbs, R.J.B.; Moore, J.E. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4. J. Immunol. 2017, 199, 2291–2304. [Google Scholar] [CrossRef]
Benchaib, M.A.; Bouchnita, A.; Volpert, V.; Makhoute, A. Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade. Front. Bioeng. Biotechnol. 2019, 7, 104. [Google Scholar] [CrossRef]
Wu, M.; Frieboes, H.B.; McDougall, S.R.; Chaplain, M.A.; Cristini, V.; Lowengrub, J. The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems. J. Theor. Biol. 2013, 320, 131–151. [Google Scholar] [CrossRef]
Jafarnejad, M.; Woodruff, M.C.; Zawieja, D.; Carroll, M.C.; Moore, J. Modeling Lymph Flow and Fluid Exchange with Blood Vessels in Lymph Nodes. Lymphat. Res. Biol. 2015, 13, 234–247. [Google Scholar] [CrossRef]
Galie, P.; Spilker, R.L. A Two-Dimensional Computational Model of Lymph Transport Across Primary Lymphatic Valves. J. Biomech. Eng. 2009, 131, 111004. [Google Scholar] [CrossRef] [PubMed]
Margaris, K.; Black, R.A. Modelling the lymphatic system: Challenges and opportunities. J. R. Soc. Interface 2012, 9, 601–612. [Google Scholar] [CrossRef] [PubMed]
Behringer, E.J.; Scallan, J.P.; Jafarnejad, M.; Castorena-Gonzalez, J.A.; Zawieja, S.D.; Moore, J.E.; Davis, M.J.; Segal, S.S. Calcium and electrical dynamics in lymphatic endothelium. J. Physiol. 2017, 595, 7347–7368. [Google Scholar] [CrossRef] [PubMed]
Contarino, C.; Toro, E.F. A one-dimensional mathematical model of collecting lymphatics coupled with an electro-fluid-mechanical contraction model and valve dynamics. Biomech. Model. Mechanobiol. 2018, 17, 1687–1714. [Google Scholar] [CrossRef] [PubMed]
Sibler, E.; He, Y.; Ducoli, L.; Keller, N.; Fujimoto, N.; Dieterich, L.; Detmar, M. Single-Cell Transcriptional Heterogeneity of Lymphatic Endothelial Cells in Normal and Inflamed Murine Lymph Nodes. Cells 2021, 10, 1371. [Google Scholar] [CrossRef] [PubMed]
Xiang, M.; Grosso, R.A.; Takeda, A.; Pan, J.; Bekkhus, T.; Brulois, K.; Dermadi, D.; Nordling, S.; Vanlandewijck, M.; Jalkanen, S.; et al. A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature. Front. Cardiovasc. Med. 2020, 7, 52. [Google Scholar] [CrossRef] [PubMed]
Fujimoto, N.; He, Y.; D’Addio, M.; Tacconi, C.; Detmar, M.; Dieterich, L.C. Single-cell mapping reveals new markers and functions of lymphatic endothelial cells in lymph nodes. PLOS Biol. 2020, 18, e3000704. [Google Scholar] [CrossRef]
Berendam, S.J.; Koeppel, A.F.; Godfrey, N.R.; Rouhani, S.J.; Woods, A.N.; Rodriguez, A.B.; Peske, J.D.; Cummings, K.L.; Turner, S.D.; Engelhard, V.H. Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells. Front. Immunol. 2019, 10, 816. [Google Scholar] [CrossRef]
Takeda, A.; Hollmén, M.; Dermadi, D.; Pan, J.; Brulois, K.F.; Kaukonen, R.; Lönnberg, T.; Boström, P.; Koskivuo, I.; Irjala, H.; et al. Single-Cell Survey of Human Lymphatics Unveils Marked Endothelial Cell Heterogeneity and Mechanisms of Homing for Neutrophils. Immunity 2019, 51, 561–572.e5. [Google Scholar] [CrossRef]
Acevedo-Acevedo, S.; Millar, D.C.; Simmons, A.D.; Favreau, P.; Cobra, P.F.; Skala, M.; Palecek, S.P. Metabolomics revealed the influence of breast cancer on lymphatic endothelial cell metabolism, metabolic crosstalk, and lymphangiogenic signaling in co-culture. Sci. Rep. 2020, 10, 21244. [Google Scholar] [CrossRef] [PubMed]
Aboulouard, S.; Wisztorski, M.; Duhamel, M.; Saudemont, P.; Cardon, T.; Narducci, F.; Lemaire, A.-S.; Kobeissy, F.; Leblanc, E.; Fournier, I.; et al. In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer. Cell Rep. Med. 2021, 2, 100318. [Google Scholar] [CrossRef] [PubMed]
Wertheim, K.Y.; Roose, T. A Mathematical Model of Lymphangiogenesis in a Zebrafish Embryo. Bull. Math. Biol. 2017, 79, 693–737. [Google Scholar] [CrossRef] [PubMed]
Bianchi, A.; Painter, K.; Sherratt, J.A. Spatio-temporal Models of Lymphangiogenesis in Wound Healing. Bull. Math. Biol. 2016, 78, 1904–1941. [Google Scholar] [CrossRef] [PubMed]
Tretyakova, R.; Savinkov, R.; Lobov, G.; Bocharov, G. Developing Computational Geometry and Network Graph Models of Human Lymphatic System. Computation 2017, 6, 1. [Google Scholar] [CrossRef]
Leukemia and Lymphoma Society. Available online: Https://www.lls.org/3d-model-library/lymph-node-anatomy-3d-model (accessed on 2 September 2021).
Pelon, F.; Bourachot, B.; Kieffer, Y.; Magagna, I.; Mermet-Meillon, F.; Bonnet, I.; Costa, A.; Givel, A.-M.; Attieh, Y.; Barbazan, J.; et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nat. Commun. 2020, 11, 404. [Google Scholar] [CrossRef]
Musuamba, F.T.; Skottheim Rusten, I.; Lesage, R.; Russo, G.; Bursi, R.; Emili, L.; Wangorsch, G.; Manolis, E.; Karlsson, K.E.; Kulesza, A.; et al. Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility. CPT Pharmacomet. Syst. Pharmacol. 2021, 10, 804–825. [Google Scholar] [CrossRef]
Viceconti, M.; Emili, L.; Afshari, P.; Courcelles, E.; Curreli, C.; Famaey, N.; Geris, L.; Horner, M.; Jori, M.C.; Kulesza, A.; et al. Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based Review. IEEE J. Biomed. Health Inform. 2021, 25, 3977–3982. [Google Scholar] [CrossRef]
Ingber, D.E. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies? Adv. Sci. 2020, 7, 2002030. [Google Scholar] [CrossRef]
Pappalardo, F.; Russo, G.; Tshinanu, F.M.; Viceconti, M. In silico clinical trials: Concepts and early adoptions. Brief. Bioinform. 2019, 20, 1699–1708. [Google Scholar] [CrossRef] [PubMed]